Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.

Cantres-Rosario Y, Plaud-Valentín M, Gerena Y, Skolasky RL, Wojna V, Meléndez LM.

AIDS. 2013 Jan 28;27(3):347-56. doi: 10.1097/QAD.0b013e32835b3e47.

2.

HIV-infected microglia mediate cathepsin B-induced neurotoxicity.

Zenón F, Cantres-Rosario Y, Adiga R, Gonzalez M, Rodriguez-Franco E, Langford D, Melendez LM.

J Neurovirol. 2015 Oct;21(5):544-58. doi: 10.1007/s13365-015-0358-7. Epub 2015 Jun 20.

PMID:
26092112
3.

Macrophage derived cystatin B/cathepsin B in HIV replication and neuropathogenesis.

Rivera LE, Colon K, Cantres-Rosario YM, Zenon FM, Melendez LM.

Curr HIV Res. 2014;12(2):111-20. Review.

4.

Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis.

Rodriguez-Franco EJ, Cantres-Rosario YM, Plaud-Valentin M, Romeu R, Rodríguez Y, Skolasky R, Meléndez V, Cadilla CL, Melendez LM.

PLoS One. 2012;7(5):e36571. doi: 10.1371/journal.pone.0036571. Epub 2012 May 31.

5.

Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women.

Gerena Y, Skolasky RL, Velez JM, Toro-Nieves D, Mayo R, Nath A, Wojna V.

PLoS One. 2012;7(5):e37358. doi: 10.1371/journal.pone.0037358. Epub 2012 May 22.

6.

Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis.

Haves-Zburof D, Paperna T, Gour-Lavie A, Mandel I, Glass-Marmor L, Miller A.

J Cell Mol Med. 2011 Nov;15(11):2421-9. doi: 10.1111/j.1582-4934.2010.01229.x.

7.

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.

PMID:
12563091
8.

Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages.

Zenón F, Segarra AC, Gonzalez M, Meléndez LM.

J Neuroimmune Pharmacol. 2014 Dec;9(5):703-15. doi: 10.1007/s11481-014-9563-z. Epub 2014 Sep 11.

9.

Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load.

Karlsson U, Antonsson L, Ljungberg B, Medstrand P, Esbjörnsson J, Jansson M, Gisslen M.

AIDS. 2012 Sep 10;26(14):1739-44. doi: 10.1097/QAD.0b013e3283560791.

PMID:
22695299
10.

Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.

Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D.

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):234-43. doi: 10.1097/QAI.0b013e318256f3bc.

11.

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S.

AIDS. 2012 Sep 10;26(14):1765-74. doi: 10.1097/QAD.0b013e328355e6b2.

12.
13.

Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders.

Fields J, Dumaop W, Adame A, Ellis RJ, Letendre S, Grant I, Masliah E.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1197-209. doi: 10.1007/s11481-013-9511-3. Epub 2013 Nov 30.

14.

Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.

Trinkaus M, Vranic A, Dolenc VV, Lah TT.

Int J Biol Markers. 2005 Jan-Mar;20(1):50-9.

PMID:
15832773
15.

Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women.

Morales D, Acevedo SF, Skolasky RL, Hechavarria R, Santiago S, De La Torre T, Maldonado E, Wojna V.

J Neurovirol. 2012 Dec;18(6):488-502. doi: 10.1007/s13365-012-0128-8. Epub 2012 Sep 13.

16.

Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care.

McCombe JA, Vivithanaporn P, Gill MJ, Power C.

HIV Med. 2013 Feb;14(2):99-107. doi: 10.1111/j.1468-1293.2012.01043.x. Epub 2012 Sep 20.

17.

Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-β and role played in cell migration.

Staun-Ram E, Miller A.

J Neuroimmunol. 2011 Mar;232(1-2):200-6. doi: 10.1016/j.jneuroim.2010.10.015. Epub 2010 Nov 26.

PMID:
21112096
18.

Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.

Hansen T, Petrow PK, Gaumann A, Keyszer GM, Otto M, Kirkpatrick CJ, Kriegsmann J.

Mod Pathol. 2001 Apr;14(4):318-24.

19.

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.

McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER.

Ann Neurol. 1997 Nov;42(5):689-98.

PMID:
9392567
20.

Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases.

Nagai A, Murakawa Y, Terashima M, Shimode K, Umegae N, Takeuchi H, Kobayashi S.

Neurology. 2000 Dec 26;55(12):1828-32.

PMID:
11134381
Items per page

Supplemental Content

Write to the Help Desk